Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Vitamin D and nonalcoholic fatty liver disease.

Zhang Z, Thorne JL, Moore JB.

Curr Opin Clin Nutr Metab Care. 2019 Nov;22(6):449-458. doi: 10.1097/MCO.0000000000000605.

2.

Taxing confectionery, biscuits, and cakes to control obesity.

Moore JB, Fielding BA.

BMJ. 2019 Sep 4;366:l5298. doi: 10.1136/bmj.l5298. No abstract available.

PMID:
31484653
3.

Getting energy balance right in an obesogenic world.

Moore JB, Boesch C.

Proc Nutr Soc. 2019 Aug;78(3):259-261. doi: 10.1017/S0029665118002720.

PMID:
31385568
4.

Phytosterols Inhibit Side-Chain Oxysterol Mediated Activation of LXR in Breast Cancer Cells.

Hutchinson SA, Lianto P, Moore JB, Hughes TA, Thorne JL.

Int J Mol Sci. 2019 Jul 2;20(13). pii: E3241. doi: 10.3390/ijms20133241.

5.

Predicting and reducing hepatic lipotoxicity in non-alcoholic fatty liver disease.

Moore JB, Thorne JL.

Lab Anim (NY). 2019 May;48(5):143-144. doi: 10.1038/s41684-019-0291-0. No abstract available.

6.

From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis.

Moore JB.

Proc Nutr Soc. 2019 Aug;78(3):290-304. doi: 10.1017/S0029665119000570. Epub 2019 Mar 29.

7.

Development and relative validation of a short food frequency questionnaire for assessing dietary intakes of non-alcoholic fatty liver disease patients.

Bredin C, Naimimohasses S, Norris S, Wright C, Hancock N, Hart K, Moore JB.

Eur J Nutr. 2019 Feb 25. doi: 10.1007/s00394-019-01926-5. [Epub ahead of print]

8.

Evaluation of the nutrient content of yogurts: a comprehensive survey of yogurt products in the major UK supermarkets.

Moore JB, Horti A, Fielding BA.

BMJ Open. 2018 Sep 18;8(8):e021387. doi: 10.1136/bmjopen-2017-021387.

9.

Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease.

Maldonado EM, Fisher CP, Mazzatti DJ, Barber AL, Tindall MJ, Plant NJ, Kierzek AM, Moore JB.

NPJ Syst Biol Appl. 2018 Aug 20;4:33. doi: 10.1038/s41540-018-0070-3. eCollection 2018.

10.

Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease.

Spanos C, Maldonado EM, Fisher CP, Leenutaphong P, Oviedo-Orta E, Windridge D, Salguero FJ, Bermúdez-Fajardo A, Weeks ME, Evans C, Corfe BM, Rabbani N, Thornalley PJ, Miller MH, Wang H, Dillon JF, Quaglia A, Dhawan A, Fitzpatrick E, Moore JB.

Proteome Sci. 2018 Jun 25;16:13. doi: 10.1186/s12953-018-0142-8. eCollection 2018.

11.

Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease.

Spanos C, Maldonado EM, Fisher CP, Leenutaphong P, Oviedo-Orta E, Windridge D, Salguero FJ, Bermúdez-Fajardo A, Weeks ME, Evans C, Corfe BM, Rabbani N, Thornalley PJ, Miller MH, Wang H, Dillon JF, Quaglia A, Dhawan A, Fitzpatrick E, Moore JB.

Proteome Sci. 2018 Feb 14;16:4. doi: 10.1186/s12953-018-0131-y. eCollection 2018. Erratum in: Proteome Sci. 2018 Jun 25;16:13. Bernadette Moore, J [corrected to Moore, J Bernadette].

12.

Integration of Genome Scale Metabolic Networks and Gene Regulation of Metabolic Enzymes With Physiologically Based Pharmacokinetics.

Maldonado EM, Leoncikas V, Fisher CP, Moore JB, Plant NJ, Kierzek AM.

CPT Pharmacometrics Syst Pharmacol. 2017 Nov;6(11):732-746. doi: 10.1002/psp4.12230. Epub 2017 Sep 8.

13.

Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review.

Kenneally S, Sier JH, Moore JB.

BMJ Open Gastroenterol. 2017 Jun 1;4(1):e000139. doi: 10.1136/bmjgast-2017-000139. eCollection 2017.

14.

Systematic Review: Nutrition and Physical Activity in the Management of Paediatric Nonalcoholic Fatty Liver Disease.

Gibson PS, Lang S, Dhawan A, Fitzpatrick E, Blumfield ML, Truby H, Hart KH, Moore JB.

J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):141-149. doi: 10.1097/MPG.0000000000001624. Review.

15.

Sugar and metabolic health: is there still a debate?

Moore JB, Fielding BA.

Curr Opin Clin Nutr Metab Care. 2016 Jul;19(4):303-9. doi: 10.1097/MCO.0000000000000289. Review.

16.

Assessment of Diet and Physical Activity in Paediatric Non-Alcoholic Fatty Liver Disease Patients: A United Kingdom Case Control Study.

Gibson PS, Lang S, Gilbert M, Kamat D, Bansal S, Ford-Adams ME, Desai AP, Dhawan A, Fitzpatrick E, Moore JB, Hart KH.

Nutrients. 2015 Nov 26;7(12):9721-33. doi: 10.3390/nu7125494.

17.

Sample Preparation Approaches for iTRAQ Labeling and Quantitative Proteomic Analyses in Systems Biology.

Spanos C, Moore JB.

Methods Mol Biol. 2016;1394:15-24. doi: 10.1007/978-1-4939-3341-9_2.

PMID:
26700038
18.

The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.

Moore JB, Gunn PJ, Fielding BA.

Nutrients. 2014 Dec 10;6(12):5679-703. doi: 10.3390/nu6125679. Review.

19.

Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease.

Fisher CP, Kierzek AM, Plant NJ, Moore JB.

World J Gastroenterol. 2014 Nov 7;20(41):15070-8. doi: 10.3748/wjg.v20.i41.15070. Review.

20.

QSSPN: dynamic simulation of molecular interaction networks describing gene regulation, signalling and whole-cell metabolism in human cells.

Fisher CP, Plant NJ, Moore JB, Kierzek AM.

Bioinformatics. 2013 Dec 15;29(24):3181-90. doi: 10.1093/bioinformatics/btt552. Epub 2013 Sep 23.

Supplemental Content

Loading ...
Support Center